| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1684 | 2020 |
| Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors E Liu, D Marin, P Banerjee, HA Macapinlac, P Thompson, R Basar, ... New England Journal of Medicine 382 (6), 545-553, 2020 | 1538 | 2020 |
| Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity E Liu, Y Tong, G Dotti, H Shaim, B Savoldo, M Mukherjee, J Orange, ... Leukemia 32 (2), 520-531, 2018 | 630 | 2018 |
| Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ... Blood, The Journal of the American Society of Hematology 137 (5), 624-636, 2021 | 184 | 2021 |
| Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells H Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ... The Journal of Clinical Investigation 131 (14), 2021 | 153 | 2021 |
| Next-generation cell therapies: the emerging role of CAR-NK cells R Basar, M Daher, K Rezvani Hematology 2014, the American Society of Hematology Education Program Book …, 2020 | 130 | 2020 |
| Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway K Kondo, H Shaim, PA Thompson, JA Burger, M Keating, Z Estrov, ... Leukemia 32 (4), 960-970, 2018 | 128 | 2018 |
| IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation A Sarvaria, R Basar, RS Mehta, H Shaim, M Muftuoglu, A Khoder, ... Blood, The Journal of the American Society of Hematology 128 (10), 1346-1361, 2016 | 96 | 2016 |
| Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated blood and cord blood–derived NK cells facilitates CAR-like responses against CD30+ malignancies LN Kerbauy, ND Marin, M Kaplan, PP Banerjee, MM Berrien-Elliott, ... Clinical Cancer Research 27 (13), 3744-3756, 2021 | 93 | 2021 |
| Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation T Sekine, D Marin, K Cao, L Li, P Mehta, H Shaim, C Sobieski, R Jones, ... Blood, The Journal of the American Society of Hematology 128 (2), 297-312, 2016 | 67 | 2016 |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape Y Li, R Basar, G Wang, E Liu, JS Moyes, L Li, LN Kerbauy, N Uprety, ... Nature medicine 28 (10), 2133-2144, 2022 | 57 | 2022 |
| A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy A Alsuliman, SH Appel, DR Beers, R Basar, H Shaim, I Kaur, J Zulovich, ... Cytotherapy 18 (10), 1312-1324, 2016 | 47 | 2016 |
| Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia MR Gaballa, P Banerjee, DR Milton, X Jiang, C Ganesh, S Khazal, ... Blood, The Journal of the American Society of Hematology 139 (12), 1908-1919, 2022 | 45 | 2022 |
| GMP-compliant universal antigen presenting cells (uAPC) promote the metabolic fitness and antitumor activity of armored cord blood CAR-NK cells E Liu, SOT Ang, L Kerbauy, R Basar, I Kaur, M Kaplan, L Li, Y Tong, ... Frontiers in immunology 12, 626098, 2021 | 34 | 2021 |
| Evidence for B cell exhaustion in chronic graft-versus-host disease A Khoder, A Alsuliman, R Basar, C Sobieski, K Kondo, AM Alousi, ... Frontiers in immunology 8, 1937, 2018 | 33 | 2018 |
| Third-party BK virus-specific cytotoxic T lymphocyte therapy for hemorrhagic cystitis following allotransplantation A Olson, R Lin, D Marin, H Rafei, MH Bdiwi, PF Thall, R Basar, ... Journal of Clinical Oncology 39 (24), 2710-2719, 2021 | 32 | 2021 |
| Bi-order multimodal integration of single-cell data J Dou, S Liang, V Mohanty, Q Miao, Y Huang, Q Liang, X Cheng, S Kim, ... Genome biology 23 (1), 112, 2022 | 31 | 2022 |
| Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells R Basar, M Daher, N Uprety, E Gokdemir, A Alsuliman, E Ensley, G Ozcan, ... Blood advances 4 (14), 3357-3367, 2020 | 30 | 2020 |
| A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation L Li, H Chen, D Marin, Y Xi, Q Miao, J Lv, PP Banerjee, H Shaim, M Daher, ... Blood Advances 3 (23), 4117-4130, 2019 | 29 | 2019 |
| The cXcr4–sTaT3–il-10 Pathway controls the immunoregulatory Function of chronic lymphocytic leukemia and is Modulated by lenalidomide H Shaim, Z Estrov, D Harris, M Hernandez Sanabria, Z Liu, P Ruvolo, ... Frontiers in immunology 8, 1773, 2018 | 29 | 2018 |
